ArticleTropical animal health and production2022
Pilot serosurvey of Coxiella burnetii in domesticated small ruminants in the United Arab Emirates.
Article in Tropical animal health and production, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers, 1 of them a synthesis that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
3 citing papers in PubMed, 1 synthesis or guideline pooled it, 3 citations in OpenAlex.
- Pooled it
- A review of coxiellosis (Q fever) and brucellosis in goats and humans: Implications for disease control in smallholder farming systems in Southeast Asia.One health (Amsterdam, Netherlands) · 2023Review
- Molecular detection ofFrontiers in microbiology · 2023Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
10 authors at 1 institution in 1 country.
Funding
Abstract
The seroprevalence of Coxiella burnetii in goats and sheep in the UAE was evaluated by ELISA testing of 437 small ruminant sera samples from livestock farms (LivF) and 478 from the Al Ain livestock market (AALM), and the data from the pilot serosurvey were analyzed using the z-test of two proportions and Fisher's method. The overall proportion of C. burnetii-seropositive goats of 32.1% was significantly higher than 24.7% for seropositive sheep (p < 0.05). On the other hand, the difference in the proportions of C. burnetii-seropositive sheep from the LivF (27.9%) and AALM (21.7%) was not statistically significant (p > 0.05). By comparison, the proportion of C. burnetii-seropositive goats from LivFs was 31.6% compared to 32.5% for the goats from the AALM (p > 0.05). In addition, there was variability in the proportions of C. burnetii-seropositive goats and sheep from the different Emirates, but none of differences was statistically significant (p > 0.05). These data provide the first evidence of apparent C. burnetii infections in goat and sheep herds in the UAE with seropositivity rate that is significantly higher in goats than sheep. The epidemiology and animal and public health implications of this pathogen need to be thoroughly evaluated in the UAE.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.